Yang Cyclization of
R-Oxoamides
A R T I C L E S
equiv of chiral amino alcohol. After the reaction mixture was stirred
at room temperature for 2 h, the reaction was quenched by adding water,
and the organic layer was separated and dried over MgSO4. Later the
silyl-protected amino alcohol coupled R-oxoamide was purifed using
column chromatography with hexane and ethyl acetate as the eluent in
the ratio 8:2. The purified product was obtained in 75% yield, 115
mg.
c. Conversion of Silyl Derivatives to Free Amino Alcohols. The
purified silyl derivative (100 mg) was dissolved in dry THF in a flame-
dried round-bottom flask and was kept under a N2 atmosphere. To this
solution was added 1.2 equiv of tetrabutylammonium fluoride solution
(1 M solution in THF), and the reaction mixture was allowed to stir
for 30 min. Purification of the product was done using column
chromatography with hexane and ethyl acetate as the eluent in the ratio
7:3. After rotovapping and drying amide 5 was obtained as a white
powder (65 mg, 82%). Similar synthetic procedures (a-c) were adopted
for the synthesis of compounds 6-8.
Spectral Data for Compounds 1-10. 4-(Aminoformyl-N,N-
diisopropylformyl)-N-((R)-1-phenylethyl)benzamide (1). 1H NMR
(CDCl3, 400 MHz, δ, ppm): 1.15 (d, 6H, J ) 6.8 Hz), 1.56 (d, 6H, J
) 6.8 Hz), 1.62(d, 3H), 3.6 (m, 2H), 5.3 (q, 1H), 6.45 (d, 1H), 7.25-
7.4 (m, 5H), 7.87 (d, 2H), 7.93 (d, 2H). 13C NMR (CDCl3, 100 MHz,
δ, ppm): 20.4, 20.5, 21, 46.2, 50.0, 51.0, 52, 66.2, 126.5, 127.8, 127.9,
129.1, 129.95, 132, 134.2, 134.6, 135.5, 138, 143, 166, 167, 190.1.
GC-MS (EI): m/e 380 (M+), 252 (20), 225 (3), 148 (3), 128 (81),
105 (19), 86 (100), 43 (56).
4-(Aminoformyl-N,N-diisopropylformyl)-N-(1-hydroxy-3-phenyl-
propan-2-ylbenzamide (8). 1H NMR (CDCl3, 400 MHz, δ, ppm):
1.1-1.18 (m, 6H), 1.56-1.6 (d, 6H, J ) 6.8 Hz), 2.96-3.02 (d, 2H,
J ) 2.4 Hz), 3.54-3.64 (m, 2H), 3.64-3.84 (m, 2H), 4.3-4.4 (m,
1H), 5.2-5.25 (m, 1H), 7.25-7.4 (m, 5H), 7.42 (d, 1H), 7.808-7.88
(m, 4H). 13C NMR (CDCl3, 100 MHz, δ, ppm): 20.4, 20.5, 20.6, 20.8,
46.2, 50.6, 56.5, 66.2, 127, 128.1, 128.3, 129.1, 129.8, 135.2, 139.1,
139.9, 167, 190.1.
3-(Aminoformyl-N,N-diisopropylformyl)-N-((R)-1-phenylethyl)-
benzamide (9). 1H NMR (CDCl3, 400 MHz, δ, ppm): 1.0 (d, 6H, J )
6.8 Hz), 1.2 (d, 3H), 1.4 (d, 6H, J ) 6.8 Hz), 3.3-3.5 (2H, m), 5.06
(m, 1H), 6.3 (d, 1H), 7.25-7.36 (m, 5H), 7.4 (m, 1H), 7.82 (m, 1H),
7.9 (m, 1H), 8.1 (m, 1H). 13C NMR (CDCl3, 100 MHz, δ, ppm): 20.5,
20.6, 21, 46.2, 50.0, 51.0, 52, 66.2, 127, 128.1, 129.1, 129.8, 132, 134,
135.5, 138, 143, 166, 167, 190.1. GC-MS (EI): m/e 380 (M+), 252
(20), 225 (3), 148 (3), 128 (81), 105 (19), 86 (100), 43 (56).
3-(Aminoformyl-N,N-diisopropylformyl)-N-((S)-1-naphthalen-1-
1
ylethyl)benzamide (10). H NMR (CDCl3, 400 MHz, δ, ppm): 1.06
(d, 3H, J ) 8.0), 1.12 (d, 3H, J ) 8.0 Hz), 1.4 (d, 3H, J ) 8.0 Hz),
1.51 (d, 3H, J ) 8.0 Hz), 1.77 (d, 3H, J ) 8.0 Hz), 3.46-3.62 (m,
2H), 6.12 (m, 1H), 6.54 (d, 1H), 7.4-7.6 (m, 5H), 7.8-8.1 (m, 6H).
13C NMR (CDCl3, 100 MHz, δ, ppm): 20.3, 20.4, 20.6, 45, 46, 50,
123, 123.5, 126, 126.2, 127, 127.3, 129, 129.3, 130, 132, 133, 134,
134.5, 135, 138, 165, 166.5, 190. GC-MS (EI): m/e 430 (M+), 302
(7), 275 (3), 260 (3), 231 (2), 155 (30), 128 (100), 104 (9), 86 (94), 76
(8).
4-(Aminoformyl-N,N-diisopropylformyl)-N-((R)-3-methylbutan-
2-yl)benzamide (2). H NMR (CDCl3, 400 MHz, δ, ppm): 0.945-
Irradiation Procedures. a. Solution. Reaction solutions (with <4
mg of ketone) were purged by bubbling nitrogen through the solution
for at least 15 min prior to irradiation. During the irradiations the
reaction vessel was sealed. Photoproducts were monitored using GC,
GC-MS, and TLC. The percent conversion was kept within 50-60%
to avoid the formation of secondary products. For HPLC analysis the
solution-irradiated sample was dissolved in appropriate solvents (iPrOH)
and used for analyses.
b. Solid State. The ketones (∼2-3 mg), either as ground single
crystals or in polycrystalline form (powder), were sandwiched between
two Pyrex plates and spread out to cover a surface area of 2-3 cm2.
The plates were sealed with Parafilm on all sides before the irradiation
process. After irradiation the solid was dissolved in appropriate solvents,
and the products were analyzed using GC, GC-MS, and TLC. For
HPLC analysis the solution-irradiated sample was dissolved in ap-
propriate solvents (iPrOH) and used for analyses. For studies on the
single-crystal-single-crystal reaction after the X-ray crystal structure
of the reactant crystal was obtained, the mounted crystal was placed
between Pyrex plates, the corners were completely sealed with Parafilm,
and the crystal was irradiated in the UV chamber. The same crystal
was irradiated for different intervals of time and the X-ray crystal
structure determined after each interval.
1
0.973 (dd, 6H, J ) 6.8, 4.4 Hz), 1.146-1.167 (dd, 6H, J ) 6.8, 2 Hz),
1.18-1.152 (d, 3H, J ) 6.8 Hz), 1.56 (d, 6H, J ) 6.8 Hz), 1.9 (m,
1H), 3.56-3.68 (m, 2H), 4.04-4.12 (m, 1H), 6.02 (d, 1H), 7.84 (d,
2H), 7.96 (d, 2H). 13C NMR (CDCl3, 100 MHz, δ, ppm): 17.79, 18.74,
18.89, 20.48, 20.5, 20.78, 21.78, 33.3, 46.39, 50.46, 51.03, 127.68,
129.94, 135.4, 140.5, 166, 166.6, 190.32. Mass spectral data: m/e
(relative intensity) 346 (M+, 1), 303 (1), 260 (4), 218 (11), 191 (3),
148 (2), 128 (60), 104 (33), 86 (100), 43 (97).
2-(4-Diisopropylaminooxalylbenzoylamino)-(S)-3-phenylpro-
1
pionic Acid Methyl Ester (3). H NMR (CDCl3, 400 MHz, δ, ppm):
1.14-1.18 (dd, 6H, J ) 6.8, 2.0 Hz), 1.55 (d, 6H), 3.2-3.34 (m, 2H),
3.56-3.68 (2H, m), 3.78 (3H, s), 5.08 (m, 1H), 6.67 (d, 1H), 7.0-7.3
(m, 5H), 7.8 (d, 2H), 7.9 (d, 2H).
2-(4-Diisopropylaminooxalylbenzoylamino)-3-((S)-4-hydroxy-
phenyl)propionic Acid Methyl Ester (4). 1H NMR (CDCl3, 400 MHz,
δ, ppm): 1.16-1.2 (dd, 6H, J ) 6.8, 2.0 Hz), 1.56 (d, 6H, J ) 6.8
Hz), 3.085-3.223 (m, 2H), 3.577-3.653 (2H, m), 3.76 (3H, s), 4.98-
5.2 (m, 1H), 6.75 (d, 1H), 6.86 (d, 2H), 7.8 (d, 2H), 7.94 (d, 2H).
4-Diisopropylaminooxalyl-N-((1S,2S)-2-hydroxy-1-methoxymethyl-
1
2-phenylethyl)benzamide (5). H NMR (CDCl3, 400 MHz, δ, ppm):
1.07-1.12 (dd, 6H, J ) 6.8, 2.0 Hz), 1.48-1.52 (d, 6H, J ) 6.8),
3.48-3.65 (m, 4H), 3.9 (s, 3H), 4.32-4.38 (m, 1H), 5.04 (d, 1H, J )
3.6 Hz), 6.85(d, 1H), 7.16-7.36 (m, 5H), 7.72 (d, 2H), 7.88 (d, 2H).
4-(Aminoformyl-N,N-diisopropylformyl)-N-((1R,2S)-1-hydroxy-
1-phenylpropan-2-yl)-N-methylbenzamide (6). 1H NMR (CDCl3, 400
MHz, δ, ppm): 1.1 (d, 6H, J ) 6.8 Hz), 1.34 (d, 3H, J ) 6.8 Hz),
1.52 (d, 6H, J ) 6.8 Hz), 2.58-2.98 (two s, 3H), 3.48-3.8 (3H, m),
4.6-4.92 (two m, 1H), 6.86-7.0 (two d, 1H), 7.25-7.42 (m, 6H),
7.76-7.88 (two d, 2H). Mass spectral data: m/e (relative intensity)
424 (M+, 1), 317 (42), 296 (5), 260 (100), 251 (3), 233 (5), 190 (3),
161 (5), 132 (17), 128 (25), 104 (33), 86 (55).
2-(4-(1-(2-Hydroxy-1-phenylethylamino)vinylphenyl)-N,N-diiso-
propyl-2-oxoacetamide (7). 1H NMR (CDCl3, 400 MHz, δ, ppm): 1.15
(dd, 6H, J ) 6.8, 2.0 Hz), 1.57 (d, 6H, J ) 6.8 Hz), 3.54-3.64 (m,
2H), 3.88-3.96 (m, 2H), 5.2-5.25 (m, 1H), 7.25-7.4 (m, 5H), 7.42
(d, 1H), 7.808-7.88 (m, 4H). 13C NMR (CDCl3, 100 MHz, δ, ppm):
20.5, 20.6, 20.7, 46.2, 50.6, 56.5, 66.2, 127, 128.1, 129.1, 129.8, 135.2,
139.1, 139.9, 167, 190.1.
Reaction Conversion Determinations. Conversions were deter-
mined on the basis of the results of GC analysis. The difference in the
GC detector response for starting material and its reaction products
was found to be negligible (all are structural isomers in most cases).
Thus, no correction was made to the integration data.
Analysis Conditions. HPLC and GC conditions for â-lactam
photoproducts of substrates are given below. All the samples were
monitored at 254 nm. The solvent composition of the eluent and the
retention times for individual diastereomers are as follows: (oxoamide
1) HPLC-chiralcel-OD, mobile phase 90:10 hexane to 2-propanol; flow
rate 0.7 mL/min; retention time of diastereomers, 48.5 and 55.4 min;
(oxoamide 2) HPLC-chiralcel-OJ, mobile phase 95:5 hexane to
2-propanol; flow rate 0.7 mL/min; retention time of diastereomers, 28.3
and 37 min; (oxoamide 3) HPLC-chiralcel-OD, mobile phase 80:20
hexane to 2-propanol; flow rate 0.5 mL/min; retention time of
diastereomers, 24.3 and 30.0 min; (oxoamide 4) HPLC-chiralpak-AD,
mobile phase 80:20 hexane to 2-propanol; flow rate 0.6 mL/min;
retention time of diastereomers, 34.0 and 56.0 min; (oxoamide 5)
9
J. AM. CHEM. SOC. VOL. 127, NO. 10, 2005 3575